The Antidepressant Web: Marketing depression and making medicines work
The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
This paper was conceived as chapters two and three of the still unwritten book, and as a basis for discussion on an Internet website and elsewhere. These chapters examine hard evidence relating to a wholly rhetorical and hypothetical question, "Do antidepressants work?" The question provides the broadest possible framework for looking at the meaning and values of medicine. Implicitly, the question also asks: what is better than nothing, and how much better are antidepressant drugs than the placebos they are compared with in clinical trials? Between the lines of the paper lie basic questions about the ethics, activities, performance and impact of the three main centres of power in medicine - government, professionals and the pharmaceutical industry. The underlying issue is whether people who are miserably unfulfilled, sad, anguished or depressed are in hands as safe as they might imagine or need.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Development of a Rating Scale for Primary Depressive Illness
HAMILTON, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
A History of Psychiatry: From the Era of the Asylum to the Age of Prozac.
Herman, E., & Shorter, E. (1997) · The Journal of American History · doi:10.2307/2953108 · Cited by 1,056
Hirschfeld, R. M. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540280071036 · Cited by 895
Drugs and the treatment of psychiatric disorders
Baldessarini, R. J. (1996) · Medical Entomology and Zoology · Cited by 683
Recognition and management of depression in general practice: consensus statement
Paykel, E. S., & Priest, R. G. (1992) · BMJ · doi:10.1136/bmj.305.6863.1198 · Cited by 540
Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
Song, F., Freemantle, N., Sheldon, T. A., House, A., Watson, P., Long, A., & Mason, J. (1993) · BMJ · doi:10.1136/bmj.306.6879.683 · Cited by 399
Priest, R. G., Vize, C., Roberts, A., Roberts, M., & Tylee, A. (1996) · BMJ · doi:10.1136/bmj.313.7061.858 · Cited by 385
Withdrawal from long-term benzodiazepine treatment
Petursson, H., & Lader, M. H. (1981) · BMJ · doi:10.1136/bmj.283.6292.643 · Cited by 367
[Long-term treatment of depression].
Keller, M. B. (1994) · PubMed · Cited by 362
Jick, S. S., Dean, A. D., & Jick, H. (1995) · BMJ · doi:10.1136/bmj.310.6974.215 · Cited by 249
Cited by
Fava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000370338 · Cited by 436
Antidepressant discontinuation reactions: Are preventable and simple to treat
Haddad, P., Lejoyeux, M., & Young, A. (1998) · BMJ · doi:10.1136/bmj.316.7138.1105 · Cited by 286
Martinez, C., Rietbrock, S., Wise, L., Ashby, D., Chick, J., Moseley, J., Evans, S., & Gunnell, D. (2005) · BMJ · doi:10.1136/bmj.330.7488.389 · Cited by 240
Can long-term treatment with antidepressant drugs worsen the course of depression?
Fava, G. A. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0204 · Cited by 223
The mechanisms of tolerance in antidepressant action
Fava, G. A., & Offidani, E. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.026 · Cited by 158
“They have been described with any type of antidepressant drugs (Dilsalver, 1990), and particularly MAO inhibitors and SSRI (Lejoyeux et al., 1996; Zajecka et al., 1997; Medawar, 1997; Oliver et al., 1999; Rosenbaum et al., 1998).”
Medications as Social Phenomena
Cohen, D., McCubbin, M., Collin, J., & Pérodeau, G. (2001) · Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine · doi:10.1177/136345930100500403 · Cited by 150
“’ Ironically, within these groups the problems of addiction and withdrawal are extremely well known and a constant topic of discussion, while such issues are virtually unacknowledged by the manufacturers, regulators, and in the scientific literature (Medawar, 1997; Breggin and Cohen, 1999).”
BackgroundAn ABC of Drug-Related Problems
Meyboom, R. H. B., Lindquist, M., & Egberts, T. C. G. (2000) · Drug Safety · doi:10.2165/00002018-200022060-00001 · Cited by 174
“Another example, the question of whether deterioration in a patient’s condition after stopping an antidepressive drug is a relapse of depression or is a mistaken withdrawal reaction, has still to be unravelled.[20] Dependence is not restricted to psychotropic drugs, Table X.”
Shaping the Intimate: Influences on the Experience of Everyday Nerves
Healy, D. (2004) · Social Studies of Science · doi:10.1177/0306312704042620 · Cited by 131
Treating AIDS: Dilemmas of unequal access in Uganda
Whyte, S. R., Whyte, M. A., Meinert, L., & Kyaddondo, B. (2004) · SAHARA-J Journal of Social Aspects of HIV/AIDS · doi:10.1080/17290376.2004.9724823 · Cited by 124
Petryna, A., & Klienman, A. (2006) · Duke University Press eBooks · doi:10.1215/9780822387916-001 · Cited by 115
Incidence and determinants of long-term use of antidepressants
Meijer, W. E. E., Heerdink, E. R., Leufkens, H. G. M., Herings, R. M. C., Egberts, T. C. G., & Nolen, W. A. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0726-3 · Cited by 127
Barbui, C., Campomori, A., D’Avanzo, B., Negri, E., & Garattini, S. K. (1999) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270050127 · Cited by 110
“The de®nition of depression has changed over the years from narrow criteria describing persons with melancholia to wider criteria that identify people with mild depressive symptoms frequently linked to anxiety (Medawar 1997).”
BackgroundRecognising and managing antidepressant discontinuation symptoms
Haddad, P. M., & Anderson, I. M. (2007) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.105.001966 · Cited by 109
“It has been argued that this phenomenon demonstrates that antidepressants are addictive (Medawar, 1997) but, as discussed above, withdrawal or discontinuation symptoms on their own are insufficient to define dependence in the clinically accepted sense of the word.”
Apostol, O. (2015) · Accounting Auditing & Accountability Journal · doi:10.1108/aaaj-07-2012-01057 · Cited by 117
Suicide, depression, and antidepressants
Cipriani, A., Barbui, C., & Geddes, J. R. (2005) · BMJ · doi:10.1136/bmj.330.7488.373 · Cited by 102
Do antidepressants have any potential to cause addiction?
Haddad, P. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300321 · Cited by 89
“Medawar (1997) challenged this view and suggested that the delay in recognizing benzodiazepine dependence is being repeated with the selective serotonin reuptake inhibitors (SSRIs).”
BackgroundMedawar, C., Herxheimer, A., Bell, A., & Jofre, S. (2002) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-2002-286 · Cited by 89
Self-citationAre we going to increase the use of antidepressants up to that of benzodiazepines?
Ciuna, A., Andretta, M., Corbari, L., Levi, D., Mirandola, M., Sorio, A., & Barbui, C. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0810-8 · Cited by 87
“In recent years, however, new adverse effects have been documented for antidepressants, including the possibility of a discontinuation syndrome [8, 9].”
Biehl, J. G. (2006) · Duke University Press eBooks · doi:10.1215/9780822387916-008 · Cited by 99
Death and Dependence: Current Controversies over the Selective Serotonin Reuptake Inhibitors
Nutt, D. J. (2003) · Journal of Psychopharmacology · doi:10.1177/0269881103174019 · Cited by 84
“This debate has polarized, with some protagonists claiming that SSRIs cause a benzodiazepine-like dependence syndrome so that many patients cannot stop even though they want to (Medawar, 1997).”
BackgroundMedawar, C., & Herxheimer, A. (2004) · International Journal of Risk & Safety in Medicine · Cited by 80
Self-citationGlobalizing Human Subjects Research
Petryna, A. (2006) · Duke University Press eBooks · doi:10.1215/9780822387916-002 · Cited by 106
Pharmaceuticals in Urban Ecologies: The Register of the Local
Das, V., & Das, R. (2006) · Duke University Press eBooks · doi:10.1215/9780822387916-007 · Cited by 103
Long-Term Treatment with Antidepressant Drugs: The Spectacular Achievements of Propaganda
Fava, G. A. (2002) · Psychotherapy and Psychosomatics · doi:10.1159/000056279 · Cited by 66
Antidepressant treatment and rodent aggressive behaviour
Mitchell, P. J. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.09.029 · Cited by 72
Use of psychotropic medications in Italian children and adolescents
Clavenna, A., Rossi, E., DeRosa, M., & Bonati, M. R. (2006) · European Journal of Pediatrics · doi:10.1007/s00431-006-0244-7 · Cited by 63
“Such a context allows for other reasons and interests— those of the market—to influence the prescriptions, as with the well documented saga of psychotropic drugs in adults over the last few decades [32, 34].”
BackgroundAddiction Markets: The Case of High-Dose Buprenorphine in France
Lovell, A. M. (2006) · Duke University Press eBooks · doi:10.1215/9780822387916-006 · Cited by 86
Ulrich, S., & L??uter, J. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241110-00004 · Cited by 54
“results are also discussed in the context of the recent discussion of the true therapeutic effects of antidepressants.[17,18]”
Conflict of Interest and Special Interest Groups
Fava, G. A. (2001) · Psychotherapy and Psychosomatics · doi:10.1159/000056218 · Cited by 56
The Role of the Pharmaceutical Industry in Teaching Psychopharmacology: A Growing Problem
Brodkey, A. C. (2005) · Academic Psychiatry · doi:10.1176/appi.ap.29.2.222 · Cited by 54
Financial conflicts of interest in psychiatry.
Fava, G. A. (2007) · PubMed · Cited by 45
Pharmacotherapy of Mood Disorders and Treatment Discontinuation
LADER, M. H. (2007) · Drugs · doi:10.2165/00003495-200767120-00001 · Cited by 43
Globalization and the Pharmaceutical Industry Revisited
Busfield, J. (2003) · International Journal of Health Services · doi:10.2190/262x-56rg-m4t6-1gu5 · Cited by 37
Educating for Global Mental Health: The Adoption of SSRIs in Japan
Applbaum, K. (2006) · Duke University Press eBooks · doi:10.1215/9780822387916-004 · Cited by 52
Healy, D. (2006) · Global Pharmaceuticals · doi:10.1215/9780822387916-003 · Cited by 35
Fernandopulle, R., & Weerasuriya, K. (2003) · Drug Safety · doi:10.2165/00002018-200326040-00002 · Cited by 42
“Charles Medowar in his article ‘The antidepressant web’,[25] shows evidence for consumer reporting on antidepressants in the developed world, to be a more sensitive tool than that of the health professionals in detecting dependence to the newer antidepressants.”
BackgroundPharmaceutical Marketing - Time for Change
Buckley, J. (2004) · Jyväskylä University Digital Archive (University of Jyväskylä) · Cited by 34
Antidepressants, withdrawal, and addiction; where are we now?
Jauhar, S., Hayes, J., Goodwin, G. M., Baldwin, D. S., Cowen, P. J., & Nutt, D. J. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119845799 · Cited by 31
UNCONVENTIONAL INDICATORS OF DRUG DEPENDENCE AMONG ELDERLY LONG-TERM USERS OF BENZODIAZEPINES
Voyer, P., McCubbin, M., Cohen, D., Lauzon, S., Collin, J., & Boivin, C. (2004) · Issues in Mental Health Nursing · doi:10.1080/01612840490472138 · Cited by 34
“…with the prescribed antidepressant dose cannot be taken as an indicator of dependence as might be the case for BZDs, although all antidepressants induce withdrawal or discontinuation syndromes that might trap some users into long-term use, (Medawar, 1997; van Broekhoven, Kan, & Zitman, 2002).”
Séror, A. C. (2002) · Journal of Medical Internet Research · doi:10.2196/jmir.4.3.e21 · Cited by 31
Perceptions of young women using SSRI antidepressants — a reclassification of stigma
Knudsen, P., Hansen, E. H., & Traulsen, J. M. (2011) · International Journal of Pharmacy Practice · doi:10.1211/096176702776868415 · Cited by 28
Ethical issues in psychopharmacology
McHenry, L. (2006) · Journal of Medical Ethics · doi:10.1136/jme.2005.013185 · Cited by 34
Does placebo help establish equivalence in trials of new antidepressants?
Barbui, C., Violante, A., & Garattini, S. K. (2000) · European Psychiatry · doi:10.1016/s0924-9338(00)00233-9 · Cited by 28
Potential Sensitising Effects of Antidepressant Drugs on Depression
Fava, G. A. (1999) · CNS Drugs · doi:10.2165/00023210-199912040-00001 · Cited by 23
Increased alcohol consumption in rats after subchronic antidepressant treatment
Alén, F., Orío, L., Gorriti, M. Á., de Heras, R. G., Ramírez-López, M. T., Pozo, M. A., & de Fonseca, F. R. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000217 · Cited by 24
Do antidepressants cause dependence?
Haddad, P. M. (2005) · Epidemiologia e Psichiatria Sociale · doi:10.1017/s1121189x00006254 · Cited by 24
“…not regard antidepressants as causing dependence, or addiction, but this view has been challenged on the basis that these drugs can cause withdrawal symptoms and that in some patients these symptoms prevent antidepressants being stopped (Medawar, 1997; BBC, October 2002; May 2003, September 2004).”
INTRODUCTION: TRACING NEW PATHS IN THE ANTHROPOLOGY OF ADDICTION
Raikhel, E., & Garriott, W. (2013) · Duke University Press eBooks · doi:10.1215/9780822395874-001 · Cited by 36
Pharmaceutical industry and the market: The case of Prozac and other antidepressants
Das, A. (2011) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2011.01.002 · Cited by 22
Pharmacological stress diathesis syndromes
Healy, D., & Tranter, R. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300312 · Cited by 19
“These syndromes have been portrayed as signi®cant hazards by some pharmaceutical companies and by critics of aspects of current psychiatric practice (Medawar, 1997).”
BackgroundPersistent sexual dysfunction after early exposure to SSRIs: Systematic review of animal studies
Simonsen, A. L., Danborg, P. B., & Gøtzsche, P. C. (2016) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-160668 · Cited by 20
Adverse drug reactions: managing the risk
Jordan, S. E., JONES, R., & SARGEANT, M. P. (2009) · Journal of Nursing Management · doi:10.1111/j.1365-2834.2009.00977.x · Cited by 16
“As a result of the prevalence of antidepressant prescribing, largely emanating from primary care practitioners (Medawar 1997, Jureidini & Tonkin 2006), the WWADR profile version I requires modification.”
BackgroundLovell, A. M. (2013) · Duke University Press eBooks · doi:10.1215/9780822395874-006 · Cited by 22
High Contact: Gifts and Surveillance in Argentina
Lakoff, A. (2006) · Duke University Press eBooks · doi:10.1215/9780822387916-005 · Cited by 36
Historiography taking issue: Analyzing an experiment with heroin abusers
Dehue, T. (2004) · Journal of the History of the Behavioral Sciences · doi:10.1002/jhbs.20023 · Cited by 21
“WHY CAN’T THEY STOP?”: A Highly Public Misunderstanding of Science
CAMPBELL, N. D. (2013) · Duke University Press eBooks · doi:10.1215/9780822395874-010 · Cited by 18
Hernáez, Á. M. (2007) · Complutensian Scientific Journals (Complutense University of Madrid) · doi:10.5209/poso.23586 · Cited by 11
« Le Prozac est la meilleure de toutes les inventions »
Hernáez, Á. M. (2007) · Socio-anthropologie · doi:10.4000/socio-anthropologie.1083 · Cited by 10
Antidepressants aren't addictive: clinicians have depended on them for years
Haddad, P. M., & Anderson, I. M. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300313 · Cited by 9
“It is important to recognize that such concern, evident for example in the 1991 MORI poll for the Defeat Depression Campaign (Priest et al., 1996), predates the recent upsurge of interest in problems with antidepressant discontinuation (CSM, 1993; Medawar, 1997).”
BackgroundLeo, J. (2004) · Society · doi:10.1007/bf02688217 · Cited by 8
PLACEBOS OR PROSTHESES FOR THE WILL? Trajectories of Alcoholism Treatment in Russia
Raikhel, E. (2013) · Duke University Press eBooks · doi:10.1215/9780822395874-008 · Cited by 13
LADER, M. H. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18500-7_7 · Cited by 7
Lapeyre‐Mestre, M., Desboeuf, K., Aptel, I., Chalé, J.-J., & Montastruc, J. (1998) · Clinical Drug Investigation · doi:10.2165/00044011-199816010-00007 · Cited by 7
Treating AIDS: Dilemmas of Unequal Access in Uganda
Whyte, S. R., Whyte, M. A., Meinert, L., & Kyaddondo, B. (2006) · Duke University Press eBooks · doi:10.1215/9780822387916-009 · Cited by 24
COMMITTED TO WILL: What’s at Stake for Anthropology in Addiction
Saris, A. J. (2013) · Duke University Press eBooks · doi:10.1215/9780822395874-011 · Cited by 17
From Descartes to Desipramine: Psychopharmacology and the Self
Gold, I., & Olin, L. (2009) · Transcultural Psychiatry · doi:10.1177/1363461509102286 · Cited by 8
Feick, J. (2005) · London School of Economics and Political Science Theses Online (London School of Economics and Political Science) · Cited by 6
BALANCING ACTS: Gambling-Machine Addiction and the Double Bind of Therapeutics
Schüll, N. D. (2013) · Duke University Press eBooks · doi:10.1215/9780822395874-003 · Cited by 13
Signs of Sobriety: Rescripting American Addiction Counseling
Carr, E. S. (2013) · Duke University Press eBooks · doi:10.1215/9780822395874-007 · Cited by 19
Goldman, C. R., & Cutler, D. L. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-47558-8_13 · Cited by 5
The use of antidepressant drugs: some reasons for concern
Fava, G. A., & Tomba, E. (1998) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-1998-155 · Cited by 5
“They have been described with all types of antidepressant compound, but more particularly with MAO inhibitors and SSRI [1].”
Epistemology of the side effect: anecdote and evidence in the digital age
Lentacker, A. (2022) · BioSocieties · doi:10.1057/s41292-022-00293-5 · Cited by 4
Are antidepressants addictive?
Dean, A. J. (2002) · Drug and Alcohol Review · doi:10.1080/0959523021000037590 · Cited by 5
Garriott, W. (2013) · Duke University Press eBooks · doi:10.1215/9780822395874-009 · Cited by 7
La dépendance aux médicaments psychotropes. De la psychopharmacologie aux usages
Moigne, P. L. (2009) · Drogues santé et société · doi:10.7202/019619ar · Cited by 3
Chapter 9. Helping Individuals Withdraw from Psychiatric Drugs
Cohen, D. (2007) · Journal of College Student Psychotherapy · doi:10.1300/j035v21n03_09 · Cited by 4
A FEW WAYS TO BECOME UNREASONABLE: Pharmacotherapy Inside and Outside the Clinic
Meyers, T. (2013) · Duke University Press eBooks · doi:10.1215/9780822395874-004 · Cited by 5
Garcia, A. (2013) · Duke University Press eBooks · doi:10.1215/9780822395874-002 · Cited by 5
Vandoolaeghe, E., Vos, N. D., Demedts, P., Wauters, A., Neels, H. M., Schouwer, P. D., & Maes, M. H. J. (1999) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199901)14:1<45::aid-hup63>3.0.co;2-p · Cited by 9
Conflict of interest and the credibility of medical journals
Fava, G. A. (2003) · Epidemiologia e Psichiatria Sociale · doi:10.1017/s1121189x00005984 · Cited by 3
“A notable exception is represented by the brave battle of a British consumers' association for the recognition of withdrawal reactions following benzodiazepines (Medawar, 1992) and use of second-generation antidepressants (Medawar, 1997).”
Hansen, H. (2013) · Duke University Press eBooks · doi:10.1215/9780822395874-005 · Cited by 10
Depression and antidepressants in Australia and beyond: A critical public health analysisPreprint
Raven, M. K. (2018) · Thesis Commons (OSF Preprints) · doi:10.31237/osf.io/7wue6 · Cited by 2
Psychosomatic medicine:alive and well in the new century
Fava, G. A., Fabbri, S., Belaise, C., & Tossani, E. (2002) · Revista Portuguesa de Psicossomática · Cited by 4
British diplomat cleared of drunk flying charges: Paroxetine was involved
Herxheimer, A. (2007) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-2007-396 · Cited by 1
Afterword: Following Addiction Trajectories
Martin, E. (2013) · Duke University Press eBooks · doi:10.1215/9780822395874-012 · Cited by 2
Conflict of interest and the credibility of clinical medicine. A psychosomatic antidote
Fava, G. A. (2002) · International Congress Series · doi:10.1016/s0531-5131(02)00652-0
Von zuverlässigen Zeugen und wortloser Objektivität
Balz, V. (2015) · Springer eBooks · doi:10.1007/978-3-658-10870-0_19
Drogue d'usage, drogue d'abus; le médecin et l'usager de drogue
Jamoulle, M. (1998) · Open Repository and Bibliography (University of Liège)
Reorientation of Activities and Self-Environment Integration: A Novel Theory of ActivitiesPreprint
Agarwal, A. K. (2020) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/8jq4n
(2013) · Duke University Press eBooks · doi:10.1215/9780822395874-013
(2006) · Duke University Press eBooks · doi:10.1215/9780822387916-010
Les manifestations cliniques du sevrage après arrêt des antidépresseurs
Fava, G. A., & Peretti, C.-S. (2024) · Elsevier eBooks · doi:10.1016/b978-2-294-77932-9.00002-9
Metadata
- Authors
- Medawar, C.
- Affiliations
- Social Audit Ltd., P.O. Box 111, London NWI 8XG, UK
- Corresponding author
- Medawar, Charles
- Venue
- International Journal of Risk and Safety in Medicine
- Publisher
- SAGE Publications
- Published
- 1997
- Volume
- 10
- Issue
- 2
- Pages
- 75-126
- ISSN
- 0924-6479 (ISSN-L)
- OpenAlex
- W2280939070
- Cited by
- 92
- References
- 65
- Citations by year
- 2024: 1 · 2022: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2016: 1 · 2015: 3 · 2013: 14
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Risk & Safety in Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- antidepressants, antidepressant efficacy, placebo comparison, clinical trials, medical ethics, pharmaceutical industry, government regulation of medicine, medical professionals, patient safety, depression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.